1 min read
Meet Veristat at PHUSE US Connect: Advancing Data-Driven Clinical Development
🔬 Connecting with the Global Clinical Data and Biostatistics Community
Veristat is pleased to attend PHUSE US Connect...
Meet the Veristat team at Booth #47, April 16th and 17th in Berlin.
The Science-First CRO™ and Consultancy Ready to Advance Your Revolutionary Therapy's Development, Approval, and Commercialization
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
For 30 years, Veristat has helped pharmaceutical and biotech companies accelerate their clinical trials and commercialize their therapies by delivering Science-First solutions across the development lifecycle.
As a Science-First CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.
Don't miss this opportunity to connect with us and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.
The Science-First CRO.™
Schedule A Meeting
Veristat team member, Balma Gil, Senior Business Development Director, and Lorenzo Scalise, Business Development Manager, will be at the venue, ready to listen to your needs and share Veristat’s expertise. Discover what makes Veristat a distinguished name in the clinical research industry.
You can arrange a meeting by completing the form on the right side of this page.
Conference Details
Website: German Biotech Days
Schedule A Meeting
Meet with us at German Biotech Days 2024 by filling out the form below.